A. Sabb

发表

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503

J. Barrett, B. Harrison, G. Welmaker, 2006, Brain Research.

Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.

M. Abou-Gharbia, A. Sabb, C. Boast, 1999, Bioorganic & medicinal chemistry letters.

The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.

J. Buccafusco, M. Abou-Gharbia, S. Rosenzweig-Lipson, 2000, The Journal of pharmacology and experimental therapeutics.

Discovery of a Highly Potent, Functionally‐Selective Muscarinic M1 Agonist, WAY‐132983 Using Rational Drug Design and Receptor Modeling.

M. Abou-Gharbia, A. Sabb, C. Boast, 1999 .

WAY‐131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist

M. Abou-Gharbia, A. Sabb, D. Ho, 1997 .

Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines.

G. Welmaker, J. Nelson, S. Rosenzweig-Lipson, 2000, Bioorganic & medicinal chemistry letters.

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

B. Harrison, G. Stack, S. Rosenzweig-Lipson, 2005, Journal of Pharmacology and Experimental Therapeutics.

The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.

M. Day, T. Comery, S. Grauer, 2010, Journal of medicinal chemistry.

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity

J. Barrett, T. Comery, K. Marquis, 2007, Journal of Pharmacology and Experimental Therapeutics.

Studies on the molybdenum cofactor: model synthetic routes directed at form B

A. Sabb, E. Taylor, 1988 .

First Scale-Up: Problems and Resolutions on the Synthesis of WAY-253752, a Novel, Dual-Acting SSRI/5HT1A Antagonist

B. Harrison, G. Stack, M. Young, 2008 .

Indole): a Novel 5-ht 2c Receptor Selective Agonist with Preclinical Antipsychotic-like Activity

J. Barrett, T. Comery, S. Grauer, 2006 .

A Convenient Synthesis of t-butyl p-Aminobenzoate

A. Sabb, S. Fletcher, E. Taylor, 1984 .

Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor.

B. Harrison, G. Welmaker, S. Rosenzweig-Lipson, 2004, Bioorganic & Medicinal Chemistry Letters.

Cycloalkyl[b][1,4]benzodiazepinoindoles Are Agonists at the Human 5‐HT2C Receptor.

B. Harrison, G. Welmaker, S. Rosenzweig-Lipson, 2004 .

Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639

A. Sabb, C. Boast, M. Abelson, 1991, Pharmacology Biochemistry and Behavior.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents

I. Lucki, K. Marquis, S. Grauer, 2007, Psychopharmacology.